A Ghanaian and survivor of multiple sclerosis, Nathalie Busari, tells GRACE EDEMA how she regained her sight and the ability ...

Neurologists call for centralized policy framework & inclusion of MS in NHM, RDP & Ayushman Bharat: Nandita Vijayasimha, Bengaluru Tuesday, May 27, 2025, 08:00 Hrs [IST] Neurologi ...

Multiple sclerosis is a progressive condition where the brain and the spinal cord get affected due to damage to the myelin ...

Delhi Chapter, in collaboration with G. B. Pant Institute of Postgraduate Medical Education and Research and the Association ...

More commonly, however, the term optic neuritis is used as a synonym for idiopathic, DON associated with MS. DON is a hallmark feature of MS and often presents as the initial clinical event.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

There is a much greater need for new therapies for progressive forms of MS than for relapsing forms of the disease. While relapsing forms are characterised by sudden attacks associated with ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

UK cost-effectiveness agency NICE has backed Novartis’ Mayzent for secondary progressive multiple sclerosis (SPMS), after turning it down earlier this year in draft guidance. The change of heart ...

Purpose To report the unusual association between non-arteritic anterior ischaemic optic neuropathy (NAION) and non-ischaemic central retinal vein occlusion (CRVO) in two patients. Methods Case ...

Optic neuritis – inflammation of the optic nerve – often occurs in association with multiple sclerosis or neuromyelitis optica. It can also be caused by infections and other immunological conditions.